Article Text

Download PDFPDF

Establishment of trauma treatment teams within a regional severe trauma treatment system in China: study protocol for a national cluster-randomised trial
  1. Yu Wang1,2,
  2. Hui-Xin Liu3,
  3. Yan-Hua Wang1,2,
  4. Ya-Jun Zhang1,2,
  5. Jin-Jun Zhang4,
  6. Wei Huang1,2,
  7. Bao-Guo Jiang1,2,
  8. Tian-Bing Wang1,2
  1. 1 Department of Orthopedic and Traumatology, Peking University People’s Hospital, Beijing, China
  2. 2 Peking University Traffic Medical Center, Beijing, China
  3. 3 Department of Clinical Epidemiology, Peking University People’s Hospital, Beijing, China
  4. 4 Office of Scientific Research and Education, Beijing Emergency Center, Beijing, China
  1. Correspondence to Dr Bao-Guo Jiang; jiangbaoguo{at}vip.sina.com and Dr Tian-Bing Wang; wangtianbing{at}pku.edu.cn

Abstract

Introduction The implementation of first aid processes for patients with trauma in China faces significant challenges. These challenges include long response times of prehospital first aid services, lack of information exchange between prehospital first aid services and in-hospital emergency services, lack of a professional rescue team in the majority of hospitals, and lack of standardised training for prehospital and in-hospital emergency personnel. The purpose of the trial is to guide the establishment of an urban trauma treatment system in China, highlight the construction of a trauma treatment system tailored to the Chinese context and improve levels of medical treatment by selecting approximately 100 counties across China as pilots to establish a regional trauma treatment system.

Methods and analysis A cluster-randomised controlled trial will be performed in 98 county-level research institutes. Included research institutes will be randomised into an experimental group and a control group. Patients in both experimental and control groups will receive basic treatments. A trauma treatment team will be established in the experimental group. The primary outcome measure is in-hospital mortality rate of patients. The secondary outcome measures include mortality rate of patients within 30 days after trauma attack and within 30 days after discharge, the time between arrival in the institution and receiving consultation, and the time from admission to the start of surgery. The effects of establishment of trauma treatment teams on the treatment of severe trauma will be evaluated in all counties.

Ethics and dissemination The procedures have been approved by The Medical Ethics Committee of Peking University People’s Hospital (No.2017PHB098-01) and conform to the Declaration of Helsinki. Data will be collected and analysed in accordance with participant privacy laws and regulations. Results will be disseminated through policy briefs, workshops, peer-reviewed publications and conferences.

Trial registration number NCT03363880; Pre-results.

  • severe trauma
  • chinese trauma treatment
  • regional trauma treatment system
  • trauma treatment team

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Footnotes

  • YW and H-XL contributed equally.

  • B-GJ and T-BW contributed equally.

  • Contributors B-GJ and T-BW conceived the study and participated in its design and coordination. YW drafted the manuscript. H-XL participated in the design of the study and performed the statistical analysis. Y-JZ and J-JZ participated in the study design and coordination and helped draft the manuscript. Y-HW and WH participated in the design of the study and wrote the protocol for the analysis. All authors read, revised and approved the final manuscript.

  • Funding This study was financially supported by Peking University Clinical + X Special Research Project, No. PKU2017LCX05; Changjiang (Yangtze River) Scholar Award and Innovation Team Development Plan Program issued by the Ministry of Education of China, No. IRT_16R01; Beijing Science and Technology Plan Project, No.D161100002816001; Capital Health Development Research Project, No. 2016-1-4081.

  • Disclaimer Funders will have no involvement in the study design; data collection, management, analysis and interpretation; paper writing or decision to submit the paper for publication.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval The procedures have been approved by The Medical Ethics Committee of Peking University People’s Hospital (No.2017PHB098-01) (online supplementary additional file 4) and conform to the Declaration of Helsinki. The study protocol will not be put into clinical practice until the Medical Ethics Committee approval is received, unless this is necessary to avoid risk to participants.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.